These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Development and achievements of pharmaceutical science in the field of the organization and economics of pharmacy in the Ukraine]. Piniazhko RM; Gubskiĭ IM; Tkachuk VA; Bushkova MM; Brilova NI Farm Zh; 1974; 29(3):33-8. PubMed ID: 4840945 [No Abstract] [Full Text] [Related]
4. [Review of the bonus work payment system in pharmaceutical enterprises]. Dasiuk EV Farm Zh; 1974; 29(3):85-90. PubMed ID: 4840953 [No Abstract] [Full Text] [Related]
5. [Drugs as an economic factor]. Wülfrath H Offentl Gesundheitswes; 1970 Jul; 32(7):348-52. PubMed ID: 4247241 [No Abstract] [Full Text] [Related]
6. [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects]. Stargardt T; Schreyögg J; Busse R Gesundheitswesen; 2005 Jul; 67(7):468-77. PubMed ID: 16103970 [TBL] [Abstract][Full Text] [Related]
7. Competition is driving down prices of many high-volume pharmaceuticals. Kuntz EF Mod Healthc; 1983 Dec; 13(12):60-2. PubMed ID: 10264040 [No Abstract] [Full Text] [Related]
8. Economic problems in drug distribution. Rucker TD Inquiry; 1972 Sep; 9(3):43-50. PubMed ID: 4262974 [No Abstract] [Full Text] [Related]
9. Variability of prescription drug prices. Hayes DM; Whalley JF N C Med J; 1974 Jun; 35(6):351-3. PubMed ID: 4527228 [No Abstract] [Full Text] [Related]
10. [Organization of the work of a pharmaceutical plant]. Zozulev AA Farm Zh; 1973; 28(6):8-10. PubMed ID: 4792444 [No Abstract] [Full Text] [Related]
11. [Scientific organization of work in the pharmaceutical enterprises of Lvov Province]. Vasileva VM; Kolomiets LT Farm Zh; 1974; (1):50-2. PubMed ID: 4463028 [No Abstract] [Full Text] [Related]
12. Drug economics and the elderly: prescriptions for change. Lipton HL Bus Health; 1988 Mar; 5(5):8-11. PubMed ID: 10312402 [No Abstract] [Full Text] [Related]
13. Price and welfare effects of a pharmaceutical substitution reform. Granlund D J Health Econ; 2010 Dec; 29(6):856-65. PubMed ID: 20832130 [TBL] [Abstract][Full Text] [Related]
14. Economics of hospital pharmacy practice. I. Third-party reimbursement. Zellmer WA Am J Hosp Pharm; 1979 Feb; 36(2):169. PubMed ID: 420204 [No Abstract] [Full Text] [Related]
15. Excess profits in the drug industry and their effect on consumer expenditures. Doherty N Inquiry; 1973 Sep; 10(3):19-30. PubMed ID: 4269726 [No Abstract] [Full Text] [Related]
16. Economics of hospital pharmacy practice. II: charging for services. Zellmer WA Am J Hosp Pharm; 1979 Mar; 36(3):307-8. PubMed ID: 420222 [No Abstract] [Full Text] [Related]
17. Price controls and global pharmaceutical progress. Scherer FM Health Aff (Millwood); 2009; 28(1):w161-4. PubMed ID: 19088103 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacoeconomic analyses--chance or 4th hurdle for innovative drugs]. Krammer H Wien Med Wochenschr; 2006 Dec; 156(23-24):606-11. PubMed ID: 17211764 [TBL] [Abstract][Full Text] [Related]
19. Cost of disease and illness in the United States in the year 2000. Public Health Rep; 1978; 93(5):493-588. PubMed ID: 100825 [No Abstract] [Full Text] [Related]